Where it comes from
- Made in
- The same neurons as NPW-23
- Sent out by
- With NPW-23
- Acts on
- Hypothalamus
- Brainstem
What it does
In medicine
- No medicine copies it or blocks it, and it is not measured in people
- Nothing in the clinic would distinguish it from NPW-23: both act at the same two receptors, and no selective ligand for either receptor is in use 2
Beyond the body’s own use
- Nothing containing it is in trials, approved or obtainable outside the laboratory
- Its difference from NPW-23 is seven residues at one end and a modest loss of potency; no effect has been found that one has and the other does not 1
- What is unknown is why the longer form exists. Which of the two a tissue releases depends on how far the processing enzymes go, and no condition has been found that shifts that balance, so the ratio has never been shown to mean anything 3
Sources
- Shimomura et al., Identification of neuropeptide W as the endogenous ligand for GPR7 and GPR8, Journal of Biological Chemistry 2002
- Singh & Davenport, Neuropeptide B and W, neurotransmitters in an emerging receptor system, British Journal of Pharmacology 2006
- Tanaka et al., Characterization of a family of endogenous neuropeptide ligands for GPR7 and GPR8, PNAS 2003
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.